Reference
1. Silverio Perrotta 1, Patrick G Gallagher, Narla Mohandas. Hereditary
spherocytosis. Lancet 2008,18;372(9647):1411-26.
2. Wang, C., Cui, Y., Li, Y., Liu, X., and Han, J. A systematic review
of hereditary spherocytosis reported in Chinese biomedical journals from
1978 to 2013 and estimation of the prevalence of the disease using a
disease model. Intract Rare Dis Res 2015, 4, 76–81.
3. Deng Z, Liao L, Yang W, Lin F: Misdiagnosis of two cases of
hereditary spherocytosis in a family and review of published reports.
Clin Chim Acta, 2015, 441: 6–9.
4. Christensen RD, Yaish HM, Gallagher PG: A pediatrician’s practical
guide to diagnosing and treating hereditary spherocytosis in neonates.
Pediatrics. 2015, 2135: 1107–1114.
5. Lux, S.E., and Palek, J. Disorders of the red cell membrane. In:
Blood: Principles and Practice of Hematology, R.I. Handin, S.E. Lux, and
T.P. Stossel, eds. (Philadelphia: Lippincott), pp. 1995, 1701–1818.
6. Eber SW, Gonzalev JM, Lux ML, et al. Ankyrin-1 mutations are a major
cause of dominant and recessive hereditary spherocytosis. Nat Genet.
1996, 13:214-218.
7. Gallagher PG. Hematologically important mutations: ankyrin variants
in hereditary spherocytosis. Blood Cells Mol Dis.2005, 35:345–7.
8. Agarwal AM, Nussenzveig RH, Reading NS, Patel JL, Sangle N, Salama
ME, et al. Clinical utility of next-generation sequencing in the
diagnosis of hereditary haemolytic anaemias. Br J Haematol. 2016,
174(5): 806–14.
9. Wang K, Li M, Hakonarson H. ANNOVAR: Functional annotation of genetic
variants from next-generation sequencing data Nucleic Acids Research,
2010, 38: e164.
10. Richards S, Aziz N, Bale S, et al. Standards and Guidelines for the
Interpretation of Sequence Variants: A Joint Consensus Recommendation of
the American College of Medical Genetics and Genomics and the
Association for Molecular Pathology[J]. Genetics in Medicine
Official Journal of the American College of Medical Genetics, 2015,
17(5):405-424.
11. Hui Y. Xiong, Babak Alipanahi, Leo J. Lee, et al. The human splicing
code reveals new insights into the genetic determinants of
disease[J]. Science, 2015, 347(6218):1254806.
12. Sangerman J1, Maksimova Y, Edelman EJ, Morrow JS, Forget BG,
Gallagher PG Ankyrin-linked hereditary spherocytosis in an
African-American kindred. Am J Hematol.2008, 83(10):789-94.
13. H Nakanishi 1, A Kanzaki, A Yawata, O Yamada, Y Yawata. Ankyrin gene
mutations in japanese patients with hereditary spherocytosis. Int J
Hematol. 2001, 73(1):54-63.
13. Park J, Jeong DC, Yoo J, Jang W, Chae H, Kim J, et al. Mutational
characteristics of ANK1 and SPTB genes in hereditary spherocytosis. Clin
Genet. 2016, 90:69–78.
15. Wang C, Wei Z, Chen K, Ye F, Yu C, Bennett V, et al. Structural
basis of diverse membrane target recognitions by ankyrins. Elife. 2014,
3: e04353.
16. Hughes MR, Anderson N, Maltby S, Wong J, Berberovic Z, Birkenmeier
CS, et al. A novel ENU-generated truncation mutation lacking the
spectrin-binding and C-terminal regulatory domains of Ank1 models severe
hemolytic hereditary spherocytosis. Exp Hematol. 2011, 39:305–20 20
e1–2.
17. Guan H, Liang X, Zhang R, Wang H, Liu W, Zhang R, et al.
Identification of a de novo ANK1 mutation in a Chinese family with
hereditary spherocytosis. Hematology. 2018, 23:357–61.